Veterinary medicines

EMA is responsible for the scientific evaluation, supervision and safety monitoring of veterinary medicines in the EU. In 2021, EMA recommended 12 medicines for marketing authorisation. Of these, seven had a new active substance. Five were vaccines, including four new biotechnological vaccines. Here are some key figures on the authorisation and safety monitoring of veterinary medicines in 2021. For more detailed information, download the full annual report 2021 (PDF version).